Last reviewed · How we verify
NCT02893345
Safe@Home: A Self-Management Program for Individuals With TBI and Their Families
Phase 2 trial testing Safe@Home Intervention Group in Brain Injuries, Traumatic in 60 participants. Status unknown.
15 August 2017
Quick facts
| Lead sponsor | Shepherd Center, Atlanta GA |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 8 August 2015 |
| Primary completion | 15 August 2017 |
| Estimated completion | 15 November 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Safe@Home Intervention Group
- Usual Care Group — full drug profile →
Conditions studied
- Brain Injuries, Traumatic — all drugs for Brain Injuries, Traumatic →
Sponsor
Shepherd Center, Atlanta GA
Who can join
Adults 18 to 99, any sex, with Brain Injuries, Traumatic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
People who sustain moderate to severe traumatic brain injury (TBI) have an increased risk for unintentional injury and harm when resuming day to day activities in the home and community. People who sustain brain injuries primarily want to independently do the activities they enjoy while families primarily focus on avoiding injury or other harm events. Safe@Home is an injury prevention education and activity training program. Participants who have sustained a moderate or severe TBI receive a personalized strengths and safety risk assessment, tailored injury prevention education, and in-home training with a transition coach on self-selected activities. This study will evaluate whether the Safe@Home program reduces injuries and harm and increases clients' independence in their everyday activities in the home and community compared to a usual care control group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02893345
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Brain Injuries, Traumatic
Currently open trials in the same condition.
- NCT06898242 — Early Myofascial Manual Treatment in Subjects With Spasticity Following Acquired Brain Injury · NA · active not recruiting
- NCT06413173 — Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric) · NA · recruiting
- NCT06142435 — mTBI Identification and Monitoring Through Retinal Scanning · recruiting
- NCT05117619 — The HOME Program for Individuals With Traumatic Brain Injury and Family Members · NA · recruiting
- NCT05092295 — Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury · active not recruiting
Other Shepherd Center, Atlanta GA trials
Trials by the same sponsor.
- NCT06214208 — Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury · NA · recruiting
- NCT04243044 — Influence of Transcutaneous Spinal Stimulation Intensity on Spasticity After SCI · NA · completed
- NCT04238013 — Neuromodulation of Ankle Muscles in Persons With SCI · NA · terminated
- NCT04777149 — Random Noise Stimulation to Enhance Cortical Drive & Improve Hand Function · NA · completed
- NCT06126549 — Comparison of Two Interventions for Caregivers of Patients With Acquired Brain Injury · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02893345 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shepherd Center, Atlanta GA
- Last refreshed: 6 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02893345.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing